The United States is grappling with one of its worst-ever drug crises. Some 50 million people in the U.S. experience chronic pain daily or almost daily, and many people turn to opioid to relieve pain. That in turn leads to addiction, which is killing more than nine hundred people a week from opioid-related overdoses. Several companies have taken initiatives to create alternative methods of pain relief and prevent opioid addiction.
Read more Team Who Invented Opioid Overdose Detection Device Wins National Honors
Sana, a Colorado-based makes wearable mask that users wear over their eyes for 15 minutes before bed, or in 15-minute intervals throughout the day, to put them into a state where they feel relaxed and less pain. The Sana mask measures minute changes between each heartbeat, and administers precisely timed pulses of light and sound to stimulate the audio and visual cortex of the user’s brain, reports CNBC.
NeuroMetrix, a medical device company focused on the diagnosis and treatment of the neurological complications of diabetes, launched its breakthrough for the treatment of chronic pain, a wearable pain relief technology called Quell® 2.0 at PAINWeek 2018. The new Quell 2.0 device is smarter, more powerful and 50% smaller, and the Quell app has been totally redesigned to make it easier to use. Quell is drug-free and has been cleared by the FDA for treatment of chronic pain without a prescription.
Oska Wellness, a pioneer in technology-driven wellness solutions, announced it will debut its next-generation Oska Pulse device at Pepcom’s Digital Experience at the CES 2019.
Oska Pulse is a revolutionary drug-free pain relief device that is clinically proven to reduce inflammation, increase circulation, improve mobility and alleviate pain using Pulsed Electromagnetic Field (PEMF) technology. Key advancements of the device provide added customer convenience and include: 1) Three times longer sessions for 90-minute PEMF pain relief sessions, and 2) 50 percent longer battery life – 15-hour total run time.
Read more FDA Clears SPR Therapeutics’ Peripheral Nerve Stimulation Systems for Pain Management
A wearable device made by Cefaly for acute treatment of migraines received FDA approval in 2017. The device is placed on the forehead for one or two hours during a headache. It sends electric pulses through the skin into the trigeminal nerve in the face, producing a sedative effect to relieve pain. The wearable enables the use of medicines to be significantly reduced and the sufferer’s quality of life to be markedly improved.